The price of the deal was disclosed for the first time in bond filings, showing how it helped flip a net operating loss last ...

Quest Diagnostics Incorporated's ( NYSE:DGX ) dividend will be increasing from last year's payment of the same ...

Quest Diagnostics Inc. closed 4.61% short of its 52-week high of $178.87, which the company reached on March 10th.

Readers hoping to buy Quest Diagnostics Incorporated (NYSE:DGX) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is one business ...

Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (NYSE:DGX) with a Buy ...

Quest Diagnostics is Thursday's IBD Stock Of The Day. Shares are lingering in a buy zone, helped by a Texas court's ruling ...

The most recent lawsuit is from winter 2024, when the California attorney general announced a $5 million settlement with ...

Redburn Atlantic analyst Jamie Clark initiated coverage of Quest Diagnostics (DGX) with a Buy rating and $195 price target Don't Miss Our End ...

This was the stock's second consecutive day of gains.

Thrivent Financial for Lutherans decreased its stake in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 7.1% ...

The assays measure phosphorylated tau 181 and apolipoprotein 4 to rule out whether a patient has Alzheimer's disease.

Quest Diagnostics Inc.’s DGX investments in Advanced Diagnostics are paying off, aiming to deliver and scale innovative services that improve patient care and drive growth. The company focuses on ...